Everand Logo

Welcome to Everand!

  • STAT

    With brain trauma, surgeons don’t always know if an operation will help. Could AI change that?

    Can AI be relied on to guide treatment of TBI patients, when the consequences of a wrong decision are so catastrophic?
    by Jacquelyn Corley Aug 14, 2019 5 minutes
    Researchers are developing AI systems that would use CT scans and other data to guide treatment of patients with traumatic brain injuries.

    A paramedic gurney flies through the trauma bay carrying an unconscious elderly gentleman. He is already intubated and has a hive of doctors and nurses running alongside, placing intravenous lines and injecting medicine into his blood stream. He’s suffered a serious head injury in a car accident. With every passing minute, blood accumulates in the space above his brain, pressing on vital structures.

    It was a cold winter afternoon in 2017, and the patient had been taken to a major regional hospital. When he arrived, the neurosurgeon on call had minutes to counsel the family on the man’s prognosis, and together they needed to decide whether to operate; surgery could save the patient’s life, but it could also commit him to a life dependent on a ventilator and a feeding tube, trapped in a coma or with limited brain function. Sometimes the quality of life matters more

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About FDA Dithering On Pharma Patents, WHO Pandemic Talks, And More
    When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.
    STAT1 min read
    STAT+: Element Biosciences, An Illumina Rival, On Its Genomics Ambitions — And Why It Hasn’t Gone Public
    Element Biosciences' modest growth comes at a time when some other players are struggling in a sequencer market dominated by Illumina.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
    A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

    Related Books & Audiobooks